Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Meta Materials Inc. - Common Stock (NQ: MMAT )

0.5258 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Meta Materials Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
22 23 Next >
SEC Names Meta Materials in Pump-and-Dump Scheme Lawsuit
Meta Materials and Torchlight Energy have been named in a SEC lawsuit against eight individuals, including @MrZackMorris and @PJ_Matlock. 
Via InvestorPlace
JetBlue Airways, Pacira BioSciences And Some Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 70 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Is Meta Materials (MMTLP) Stock Getting Deleted Today?
Will MMTLP stock be deleted today? That's on the mind of every single shareholder after the surprise halt last week. 
Via InvestorPlace
Moderna (MRNA) Stock Soars on Cancer Vaccine News
Moderna (MRNA) stock is rising higher on Tuesday following the release of data from a Phase 2B cancer vaccine clinical trial. 
Via InvestorPlace
12 Information Technology Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Investors Should Bet $100 on MMAT Stock
MMAT stock investors can ignore the spinoff hubbub and focus on Meta Materials' niche-industry growth potential. 
Via InvestorPlace
Insider Thomas Welch Just Sold Meta Materials (MMAT) Stock
On December 7, 10% owner Thomas Welch sold 75,000 shares of MMAT stock at an average price of $2.23 per share. 
Via InvestorPlace
Investors Petition for FINRA to Reinstate MMTLP Stock Trading After Halt
MMTLP stock holders received a surprise last week when trading of the security was suspended. Now, shareholders have created a petition. 
Via InvestorPlace
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share. 
Via Benzinga
Why Aptevo Therapeutics Shares Are Trading Higher By More Than 100%; Here Are 28 Stocks Moving Premarket
Gainers 
Via Benzinga
12 Information Technology Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Halted Stocks Alert: Why Did FINRA Halt MMTLP Stock?
Some shareholders are angry as trading in MMTLP stock is halted ahead of Meta Materials' planned spinoff of Next Bridge Hydrocarbons. 
Via InvestorPlace
FINRA Halts Trading in Meta Materials (MMTLP) Stock Ahead of Spinoff
FINRA has halted trading on MMTLP stock ahead of Meta Materials' Next Bridge Hydrocarbons spinoff. Here's what investors need to know. 
Via InvestorPlace
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate. 
Via Benzinga
Most Active Equity Options For Midday - Friday, Dec. 9
Here are the most active equity options for midday. 
Via Talk Markets
12 Information Technology Stocks Moving In Friday's Intraday Session
Via Benzinga
Lululemon, Li Auto, Hackett Group And Some Other Big Stocks Moving Lower On Friday
U.S. stocks traded lower, with the Dow Jones jumping around 70 points on Friday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
5 Investors Betting Big on Meta Materials (MMAT) Stock Right Now
The date of record for the MMAT stock spinoff of MMTLP shares for shares of Next Bridge Hydrocarbons is quickly approaching. 
Via InvestorPlace
Meta Materials Announces FINRA Has Revised Corporate Action for Exchange of Series A Preferred
Via ACCESSWIRE
12 Information Technology Stocks Moving In Thursday's Intraday Session
Via Benzinga
Chefs' Warehouse, Chart Industries And Some Other Big Stocks Moving Lower On Thursday
U.S. stocks traded higher, with the Dow Jones jumping over 200 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Most Active Equity Options For Midday - Wednesday, Dec. 7
Here are the most active equity options for midday. 
Via Talk Markets
Why Is TransCode Therapeutics (RNAZ) Stock Up 148% Today?
TransCode Therapeutics (RNAZ) stock is rallying higher on Wednesday after the company withdrew plans for a secondary offering. 
Via InvestorPlace
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC... 
Via Benzinga
SNY Stock Alert: Why 1 Analyst Says Zantac Ruling Is ‘Best-Case Scenario’ for Drugmakers
Sanofi (SNY) stock is in the news as one analyst believes the latest court ruling is the "best-case scenario" for the drugmaker. 
Via InvestorPlace
Why Is Meta Materials (MMAT) Stock Up 9% Today?
Shares of MMAT stock are in the green after it was announced that FINRA had approved the exchange to receive Next Bridge shares. 
Via InvestorPlace
What's Going On With Meta Materials Stock Today?
Shares of Meta Materials Inc (NASDAQ: MMAT) and Meta Materials Preferred (Pink: MMTLP) are trading higher Wednesday after the company announced FINRA has processed corporate actions for the exchange of... 
Via Benzinga
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why iBio Shares Are Trading Lower By Around 48%; Here Are 23 Stocks Moving Premarket
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 71.3% to $0.7190 in pre-market trading after the company reported withdrawal of registration statement. 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.